NPs Basic Information

Name
(3S)-Alterpyrone C
Molecular Formula C14H20O4
IUPAC Name*
6-[4-(hydroxymethyl)hex-2-en-2-yl]-4-methoxy-3-methylpyran-2-one
SMILES
CCC(C=C(C)c1cc(OC)c(C)c(=O)o1)CO
InChI
InChI=1S/C14H20O4/c1-5-11(8-15)6-9(2)12-7-13(17-4)10(3)14(16)18-12/h6-7,11,15H,5,8H2,1-4H3/b9-6+/t11-/m0/s1
InChIKey
UJCVTJDOKCZSJP-LAHYYIKRSA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Pyrans
        • Subclass: Pyranones and derivatives
          • Direct Parent: Pyranones and derivatives

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 252.31 ALogp: 2.4
HBD: 1 HBA: 4
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 59.7 Aromatic Rings: 1
Heavy Atoms: 18 QED Weighted: 0.874

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.749 MDCK Permeability: 0.00001930
Pgp-inhibitor: 0.106 Pgp-substrate: 0.01
Human Intestinal Absorption (HIA): 0.014 20% Bioavailability (F20%): 0.008
30% Bioavailability (F30%): 0.223

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.901 Plasma Protein Binding (PPB): 86.44%
Volume Distribution (VD): 1.23 Fu: 19.48%

ADMET: Metabolism

CYP1A2-inhibitor: 0.89 CYP1A2-substrate: 0.923
CYP2C19-inhibitor: 0.51 CYP2C19-substrate: 0.85
CYP2C9-inhibitor: 0.448 CYP2C9-substrate: 0.596
CYP2D6-inhibitor: 0.092 CYP2D6-substrate: 0.861
CYP3A4-inhibitor: 0.427 CYP3A4-substrate: 0.474

ADMET: Excretion

Clearance (CL): 8.069 Half-life (T1/2): 0.745

ADMET: Toxicity

hERG Blockers: 0.033 Human Hepatotoxicity (H-HT): 0.781
Drug-inuced Liver Injury (DILI): 0.301 AMES Toxicity: 0.008
Rat Oral Acute Toxicity: 0.037 Maximum Recommended Daily Dose: 0.024
Skin Sensitization: 0.822 Carcinogencity: 0.244
Eye Corrosion: 0.058 Eye Irritation: 0.748
Respiratory Toxicity: 0.025
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004627 1.000 D05QDC 0.258
ENC004628 1.000 D0B1IP 0.255
ENC004941 0.500 D0L5FY 0.247
ENC004626 0.500 D06REO 0.244
ENC004940 0.468 D08VYV 0.229
ENC005948 0.456 D02XJY 0.228
ENC004939 0.444 D0O6KE 0.227
ENC004634 0.441 D03LGG 0.225
ENC005949 0.415 D0U5CE 0.225
ENC005951 0.415 D0E9CD 0.219
*Note: the compound similarity was calculated by RDKIT.